CYNTHIA STIVES: Open Payments
NPI 1861566515 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 10 payments from 8 companies in 2025. Trend: 2023 $861 · 2024 $989 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $130 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Exact Sciences Corporation | 2 | $99 |
| United Therapeutics Corporation | 2 | $95 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
Products named: REZDIFFRA, INGREZZA, AMVUTTRA, Symbravo, AREXVY, Cologuard Collection Kit, LifeVest.
Industry payments across OH — which companies pay providers there.
